Black Spade Acquisition Co - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
001-40616 |
A | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) | ||
Suite 2902, 29/F , The Centrium 60 Wyndham Street, Central Hong Kong |
A | |||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Class A ordinary shares, par value $0.0001 per share |
BSAQ |
The New York Stock Exchange | ||
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
BSAQWS |
The New York Stock Exchange | ||
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant |
BSAQU |
The New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
BLACK SPADE ACQUISITION CO
Quarterly Report on Form 10-Q
TABLE OF CONTENTS
i
Table of Contents
September 30, |
December 31, |
|||||||
2022 |
2021 |
|||||||
(unaudited) |
||||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash |
$ | 73,882 | $ | 1,569,803 | ||||
Prepaid expenses |
22,023 | 294,062 | ||||||
|
|
|
|
|||||
Total Current Assets |
95,905 | 1,863,865 | ||||||
Investments held in the Trust Account |
170,013,217 | 169,006,966 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 170,109,122 | $ | 170,870,831 | ||||
|
|
|
|
|||||
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
||||||||
Current Liabilities: |
||||||||
Accounts payable and accrued expenses |
$ | 2,579,531 | $ | 1,458,309 | ||||
Due to related party |
1,594 | 27,250 | ||||||
|
|
|
|
|||||
Total Current Liabilities |
2,581,125 | 1,485,559 | ||||||
Derivative warrant liabilities |
1,705,450 | 13,050,400 | ||||||
Deferred underwriting commission |
5,915,000 | 5,915,000 | ||||||
|
|
|
|
|||||
Total liabilities |
10,201,575 | 20,450,959 | ||||||
COMMITMENTS AND CONTINGENCIES |
||||||||
Class A ordinary shares subject to possible redemption; 16,900,000 shares (at redemption value) |
170,013,217 | 169,000,000 | ||||||
Shareholders’ deficit: |
||||||||
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value, 200,000,000 shares authorized, none issued and outstanding |
— | — | ||||||
Class B ordinary shares, $0.0001 par value, 20,000,000 shares authorized, 4,225,000 shares issued and outstanding |
422 | 422 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(10,106,092 | ) | (18,580,550 | ) | ||||
|
|
|
|
|||||
Total Shareholders’ Deficit |
(10,105,670 | ) | (18,580,128 | ) | ||||
|
|
|
|
|||||
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ | 170,109,122 | $ | 170,870,831 | ||||
|
|
|
|
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
For the Period March 3, 2021 (Inception) Through September 30, |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
EXPENSES |
||||||||||||||||
Administration fee - related party |
$ | 30,000 | $ | 25,000 | $ | 90,000 | $ | 25,000 | ||||||||
General and administrative |
295,500 | 6,004,974 | 2,773,526 | 6,027,369 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
TOTAL EXPENSES |
325,500 | 6,029,974 | 2,863,526 | 6,052,369 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
OTHER INCOME |
||||||||||||||||
Income earned on Investments held in Trust Account |
762,820 | 1,665 | 1,006,251 | 1,665 | ||||||||||||
Transaction costs allocable to derivative warrant liabilities |
— | (735,630 | ) | — | (735,630 | ) | ||||||||||
Change in fair value of derivative warrant liabilities |
68,218 | 10,138,000 | 11,344,950 | 10,138,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
TOTAL OTHER INCOME - NET |
831,038 | 9,404,035 | 12,351,201 | 9,404,035 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
505,538 | 3,374,061 | $ | 9,487,675 | $ | 3,351,666 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted weighted average shares outstanding, redeemable Class A Ordinary Shares |
16,900,000 | 12,936,957 | 16,900,000 | 5,640,758 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share of redeemable Class A Ordinary Shares |
$ | 0.02 | $ | 0.20 | $ | 0.45 | $ | 0.34 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average number of shares of non-redeemable ordinary shares outstanding, basic and diluted |
4,225,000 | 4,257,337 | 4,225,000 | 4,288,448 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share of non-redeemable ordinary shares |
$ | 0.02 | $ | 0.20 | $ | 0.45 | $ | 0.34 | ||||||||
|
|
|
|
|
|
|
|
Class B Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Shareholders’ Deficit |
|||||||||||||||||
Shares | Amount | |||||||||||||||||||
Balance as of January 1, 2022 |
4,225,000 | $ | 422 | $ | — | $ | (18,580,550 | ) | $ | (18,580,128 | ) | |||||||||
Measurement adjustment of carrying value to redemption value |
— | — | — | (22,183 | ) | (22,183 | ) | |||||||||||||
Net income |
— | — | — | 7,622,890 | 7,622,890 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of March 31, 2022 |
4,225,000 | 422 | — | (10,979,843 | ) | (10,979,421 | ) | |||||||||||||
Measurement adjustment of carrying value to redemption value |
— | — | — | (228,214 | ) | (228,214 | ) | |||||||||||||
Net income |
— | — | — | 1,359,247 | 1,359,247 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2022 |
4,225,000 | $ | 422 | $ | — | $ | (9,848,810 | ) | $ | (9,848,388 | ) | |||||||||
Measurement adjustment of carrying value to redemption value |
— | — | — | (762,820 | ) | (762,820 | ) | |||||||||||||
Net income |
— | — | — | 505,538 | 505,538 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2022 |
4,225,000 | $ | 422 | $ | — | $ | (10,106,092 | ) | $ | (10,105,670 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
Class B Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Shareholders’ Deficit |
|||||||||||||||||
Shares | Amount | |||||||||||||||||||
Balance as of March 3, 2021 (inception) |
— | $ | — | $ | — | $ | — | $ | — | |||||||||||
Issuance of Class B shares to Sponsor |
4,312,500 | 431 | 24,569 | — | 25,000 | |||||||||||||||
Net loss |
— | — | — | (13,153 | ) | (13,153 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of March 31, 2021 |
4,312,500 | 431 | 24,569 | (13,153 | ) | 11,847 | ||||||||||||||
Net loss |
— | — | — | (9,242 | ) | (9,242 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2021 |
4,312,500 | $ | 431 | $ | 24,569 | $ | (22,395 | ) | $ | 2,605 | ||||||||||
Forfeiture of Class B Ordinary Shares |
(87,500 | ) | (9 | ) | 9 | — | — | |||||||||||||
Class B Ordinary Shares transferred from Sponsor for services |
— | — | 5,761,500 | — | 5,761,500 | |||||||||||||||
Redemption adjustment of Class A ordinary shares to redemption value |
— | — | (5,786,078 | ) | (15,457,900 | ) | (21,243,978 | ) | ||||||||||||
Net income |
— | — | — | 3,374,061 | 3,374,061 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2021 |
4,225,000 | $ | 422 | $ | 24,569 | $ | (12,106,234 | ) | $ | (12,105,812 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
For the Period From March 3, 2021 (Inception) Through September 30, 2021 |
|||||||
Cash Flows From Operating Activities: |
||||||||
Net income |
$ | 9,487,675 | $ | 3,351,666 | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Investment income earned on treasury securities held in the Trust Account |
(1,006,251 | ) | (1,665 | ) | ||||
Costs associated with warrant liabilities |
— | 735,630 | ||||||
Gain on change in fair value of derivative liabilities |
(11,344,950 | ) | (10,138,000 | ) | ||||
Share-based compensation |
— | 5,761,500 | ||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
272,039 | (404,384 | ) | |||||
Accounts payable and accrued expenses |
1,121,222 | 91,309 | ||||||
|
|
|
|
|||||
Net Cash Used In Operating Activities |
(1,470,265 | ) | (603,944 | ) | ||||
|
|
|
|
|||||
Cash Flows From Investing Activities: |
||||||||
Cash deposited into the Trust Account |
— | (169,000,000 | ) | |||||
|
|
|
|
|||||
Net Cash Used In Financing Activities |
— | (169,000,000 | ) | |||||
|
|
|
|
|||||
Cash Flows From Financing Activities: |
||||||||
Sale of Units in the Initial Public Offering, net of underwriting discount |
— | 165,620,000 | ||||||
Sale of Private Placement Warrants to the Sponsor |
— | 6,380,000 | ||||||
Proceeds from related party advances |
1,594 | — | ||||||
Repayment of related party advances |
(27,250 | ) | — | |||||
Payment of offering costs |
— | (660,108 | ) | |||||
|
|
|
|
|||||
Net Cash (Used In) From Financing Activities |
(25,656 | ) | 171,339,892 | |||||
|
|
|
|
|||||
Net change in cash |
(1,495,921 | ) | ||||||
Cash at beginning of year |
1,569,803 | — | ||||||
|
|
|
|
|||||
Cash at end of year |
$ | 73,882 | $ | 1,735,948 | ||||
|
|
|
|
|||||
Supplemental disclosure of non-cash financing activities: |
||||||||
Deferred offering costs paid by Sponsor in exchange for Class B ordinary shares |
$ | — | $ | 25,000 | ||||
Deferred offering costs paid by Sponsor |
$ | — | $ | 20,600 | ||||
Measurement adjustment of carrying value to redemption value |
$ | 1,013,217 | $ | — | ||||
Deferred underwriting compensation charged to additional paid-in capital in connection with the Initial Public Offering |
$ | — | $ | 5,915,000 | |
Gross proceeds |
$ | 169,000,000 | ||
Less: |
||||
Proceeds allocated to the Public Warrants |
(11,914,500 | ) | ||
Shares of Class A ordinary share issuance costs |
(9,329,478 | ) | ||
(21,243,978 | ) | |||
Plus: |
||||
Measurement adjustment of carrying value to redemption value |
21,243,978 | |||
Class A Ordinary Shares subject to possible redemption at December 31, 2021 |
$ | 169,000,000 | ||
Measurement adjustment of carrying value to redemption value |
1,013,217 | |||
Class A Ordinary Shares subject to possible redemption at September 30, 2022 |
$ | 170,013,217 | ||
Three months Ended September 30, 2022 |
Three months ended September 30, 2021 |
|||||||
Class A Ordinary shares |
||||||||
Numerator: Income allocable to Class A ordinary shares |
$ | 404,430 | $ | 2,538,638 | ||||
Denominator: Basic and diluted weighted average shares outstanding |
16,900,000 | 12,936,957 | ||||||
Basic and diluted net income per share, Class A ordinary shares |
$ | 0.02 | $ | 0.20 | ||||
Class B Ordinary shares |
||||||||
Numerator: Income allocable to Class B ordinary shares |
$ | 101,108 | $ | 835,423 | ||||
Denominator: Basic and diluted weighted average shares outstanding |
4,225,000 | 4,257,337 | ||||||
Basic and diluted net income per share, Class B ordinary shares |
$ | 0.02 | $ | 0.20 | ||||
Nine months Ended September 30, 2022 |
For the Period from March 5, 2021 (inception) through September 30, 2021 |
|||||||
Class A Redeemable common stock |
||||||||
Numerator: Income allocable to Class A common stock |
$ | 7,590,140 | $ | 1,904,073 | ||||
Denominator: Basic and diluted weighted average shares outstanding |
16,900,000 | 5,640,758 | ||||||
Basic and diluted net income per share, Class A Common Stock |
$ | 0.45 | $ | 0.34 | ||||
Class B Non-redeemable common stock |
||||||||
Numerator: Income allocable to Class B common stock |
$ | 1,897,535 | $ | 1,447,593 | ||||
Denominator: Basic and diluted weighted average shares outstanding |
4,225,000 | 4,288,448 | ||||||
Basic and diluted net income per share, Class B Common Stock |
$ | 0.45 | $ | 0.34 | ||||
bearing. As of September 30, 2022 and December 31, 2021, there was $1,594 and $27,250 due to the related party.
• | in whole and not in part; |
• | at a price of $0.01 per Public Warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A ordinary share equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders. |
• | in whole and not in part; |
• | at a price of $0.10 per warrant provided that the holder will be able to exercise their warrants on cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary share; |
• | upon a minimum of 30 days’ prior written notice of redemption; |
• | at a price equal to a number of shares of Class A Common Stock to be determined by reference to the agreed table (i.e., “make-whole table”) set forth in the warrant agreement based on the redemption date and the “fair market value” of the Class A Common Stock; |
• | if, and only if, the last reported sale price of our Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted per share subdivisions, share dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and |
• | if, and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of Class A ordinary shares) as the outstanding public warrants, as described above. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description: |
Level |
September 30, 2022 |
Level |
December 31, 2021 |
||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account |
1 | $ | 170,013,217 | 1 | $ | 169,006,966 | ||||||||||
Liabilities: |
||||||||||||||||
Warrant liability - Private Placement Warrants |
2 | $ | 733,700 | 2 | $ | 5,614,400 | ||||||||||
Warrant liability - Public Warrants |
1 | $ | 971,750 | 1 |
$ | 7,436,000 |
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References to the “Company,” “our,” “us” or “we” refer to Black Spade Acquisition Co. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated on March 3, 2021 as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Initial Business Combination”). We intend to effectuate our Initial Business Combination using cash from the proceeds of the initial public offering (the “Initial Public Offering”) and the private placement of the Private Placement Warrants (as defined below), the proceeds of the sale of our shares in connection with our Initial Business Combination (pursuant to forward purchase agreements or backstop agreements we may enter into prior to or following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.
The issuance of additional shares in connection with an Initial Business Combination to the owners of the target or other investors:
• | may significantly dilute the equity interest of our existing investors, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and |
• | may adversely affect prevailing market prices for our Class A ordinary shares and/or warrants. |
Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:
17
Table of Contents
• | default and foreclosure on our assets if our operating revenues after an Initial Business Combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
We expect to continue to incur significant costs in the pursuit of our Initial Business Combination. We cannot assure you that our plans to raise capital or to complete our Initial Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through September 30, 2022 were organizational activities, those necessary to prepare for and consummate the Initial Public Offering. We do not expect to generate any operating revenues until after the completion of our Initial Business Combination. We generate non-operating income in the form of interest income on cash and cash equivalents. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing an Initial Business Combination.
For the three months ended September 30, 2022, we had net income of $505,538 which primarily consisted of income earned on investments held in Trust Account of $762,820 and a change in fair value of derivative warrant liabilities of $68,218 partially offset by general and administrative expenses of $295,500 and administration fee — related party $30,000. For the three months ended September 30, 2021, we had net income of $3,374,061, which primarily consisted of a change in fair value of derivative warrant liabilities of $10,138,000 and interest income of $1,665 partially offset by operating and formation costs of $6,029,974 and warrant offering costs of $735,630.
For the nine months ended September 30, 2022, we had net income of $9,487,675 which primarily consisted of a change in fair value of derivative warrant liabilities of $11,344,950 and income earned on investments held in Trust Account of $1,006,251 partially offset by general and administrative expenses of $2,773,526 and administration fee — related party of $90,000. For the period from March 3, 2021 (inception) through September 30, 2021, we had net income of $3,351,666, which primarily consisted of a change in fair value of derivative warrant liabilities of $10,138,000 and interest income of $1,665 offset by operating and formation costs of $6,052,369 and warrant offering costs of $735,630.
Liquidity and Capital Resources
Until the closing of the Initial Public Offering, our liquidity needs were satisfied through the receipt of $25,000 from an initial sale of Class B ordinary shares (the “Founder Shares”), par value $0.0001 per share, to our sponsor, Black Spade Sponsor LLC (the “Sponsor”) and an unsecured and noninterest bearing promissory note (the “Promissory Note”) issued by us to the Sponsor, pursuant to which we may borrow up to an aggregate principal amount of $250,000.
18
Table of Contents
On July 20, 2021, we consummated our Initial Public Offering of 15,000,000 units at a price of $10.00 per unit (the “Units”), generating gross proceeds of $150,000,000. Each Unit consists of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant (the “Public Warrants”), with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 6,000,000 private placement warrants to our Sponsor at a price of $1.00 per warrant (the “Initial Private Placement Warrants”), generating gross proceeds of $6,000,000.
In connection with the Initial Public Offering, the underwriters were granted a 45-day option from the date of the prospectus (the “Over-Allotment Option”) to purchase up to an additional 2,250,000 Units to cover over-allotments, if any. On August 3, 2021, the underwriters purchased an additional 1,900,000 Units (the “Option Units”) pursuant to the partial exercise of the Over-Allotment Option. The Option Units were sold at an offering price of $10.00 per Unit, generating additional gross proceeds to the Company of $19,000,000. Also in connection with the partial exercise of the Over-Allotment Option, our Sponsor purchased an additional 380,000 private placement warrants at a purchase price of $1.00 per warrant (the “Option Private Placement Warrants”, together with the Initial Private Placement Warrants, the “Private Placement Warrants”), generating additional gross proceeds to the Company of $380,000.
Following our Initial Public Offering, the partial exercise of the Over-Allotment Option and the sale of the Private Placement Warrants, a total of $169,000,000 was placed in a trust account (the “Trust Account”). We incurred $10,082,915 in offering costs, including $3,380,000 of underwriting discounts and commissions, $5,915,000 of deferred underwriting commissions and $770,108 of other offering costs.
For the nine months ended September 30, 2022, net cash used in operating activities was $1,470,265 consisting of (i) net income of $9,494,312, as adjusted by a gain on change in fair value of warrant liabilities of $11,344,950 and investment income earned on treasury securities held in the Trust Account of $1,006,251, and (ii) changes in operating assets and liabilities including prepaid expenses of $272,039 and accounts payable and accrued expenses of $1,121,222. For the period from March 3, 2021 (inception) through September 30, 2021, net cash used in operating activities was $603,944, consisting of (i) net income of $3,351,666 as adjusted by a gain on change in fair value of warrant liabilities of $10,138,000 offset by stock-based compensation of $5,761,500 and warrant offering costs of $735,630, and (ii) changes in operating assets and liabilities including cash used in prepaid expenses of $404,384 and accounts payable and accrued expenses of $91,309.
For the period March 3, 2021 (inception) through September 30, 2021, investing activities included the deposit of cash from the proceeds of the Initial Public Offering into the Trust Account of $169,000,000.
For the nine months ended September 30, 2022, net cash used in financing activities was $25,656, consisting of related party advances of $1,599 offset by the repayment of related party advances of $27,250. For the period March 3, 2021 (inception) through September 30, 2021, the Company received proceeds of $165,620,000 (net of underwriter discounts) from the Initial Public Offering, $6,380,000 from the sale of the Private Placement Warrants, which were offset by the repayment of offering costs of $660,108.
As of September 30, 2022, we had marketable securities held in the Trust Account of $170,013,217. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (excluding deferred underwriting commissions) net of any redemptions, to complete our Initial Business Combination. We may withdraw interest to pay our taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account. We expect the interest earned on the amount in the Trust Account will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2022, we had cash of $73,882 held outside the Trust Account. We intend to use the funds held outside the Trust Account following the completion of the Initial Public Offering primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
As of September 30, 2022, we had cash of $73,882 and a working capital deficit of $2,485,220. The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its Initial Business Combination. In addition, the Company expects to have negative cash flows from operations as it pursues an initial business combination target. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company does not currently have adequate liquidity to sustain operations, which consist solely of pursuing a Business Combination.
19
Table of Contents
In order to fund working capital deficiencies or finance transaction costs in connection with an Initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (the “Working Capital Loans”). If we complete our Initial Business Combination, we would repay such loaned amounts. In the event that our Initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2022, there were no amounts outstanding under the Working Capital Loans. On October 25, 2022, we issued an unsecured promissory note in the amount of up to $600,000 to our Sponsor (the “Working Capital Note”). The Working Capital Note does not bear interest and shall be payable in full upon the consummation of an Initial Business Combination. The Sponsor may elect to convert all or any portion of the unpaid principal balance of this Working Capital Note into one or more redeemable warrants (the “Working Capital Warrants”) with each $1.00 of unpaid principal balance being convertible into one Working Capital Warrant. The Working Capital Warrants shall be identical to the Private Placement Warrants.
While the Company expects to have sufficient access to additional sources of capital if necessary, there is no current commitment on the part of any financing source to provide additional capital and no assurances can be provided that such additional capital will ultimately be available. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. As is customary for a special purpose acquisition company, if the Company is not able to consummate a Business Combination during the Combination Period, it will cease all operations and redeem the Public Shares. Management plans to continue its efforts to consummate a Business Combination during the Combination Period.
If our estimate of the costs of undertaking in-depth due diligence and negotiating an Initial Business Combination is less than the actual amount necessary to do so, we may be required to raise additional capital, the amount, availability and cost of which is currently unascertainable. If we are required to seek additional capital, we may seek such additional capital through loans or additional investments from our Sponsor, members of our management team or any of their affiliates, but such persons are not under any obligation to advance funds to, or invest in, us.
Off-Balance Sheet Financing Arrangements
We had no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay our Sponsor a monthly fee of up to $10,000 for office space, utilities and secretarial and administrative support provided to the Company. We began incurring these fees on July 15, 2021 and will continue to incur these fees monthly until the earlier of the completion of our Initial Business Combination and our liquidation.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $5,915,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Class A ordinary shares subject to possible redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480.
20
Table of Contents
Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Given the above, the management determined that to the extent funds are available, shares of the Company’s redeemable equity should be reported as temporary equity. Accordingly, as of September 30, 2022, 16,900,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheet.
Net income per share
Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. The Company applies the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption at September 30, 2022, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The calculation of diluted income per ordinary share does not consider the effect of the warrants issued in connection with the (i) Public Offering, (ii) exercise of over-allotment and (iii) Private Placement, since their inclusion would be anti-dilutive under the two-class method. As a result, diluted earnings per ordinary share is the same as basic earnings per ordinary share for the periods presented. The warrants are exercisable to purchase 14,830,000 Class A ordinary shares in the aggregate.
The Company’s statement of operations includes a presentation of income per Class A ordinary share subject to possible redemption in a manner similar to the two-class method of income per ordinary share. Net income per ordinary share, basic and diluted, for redeemable Class A ordinary share is calculated by dividing the interest income by the weighted average number of redeemable Class A ordinary shares outstanding since original issuance. Net income per ordinary share, basic and diluted, for non-redeemable Class B ordinary share is calculated by dividing the net income, adjusted for loss attributable to redeemable Class A ordinary shares, by the weighted average number of non-redeemable Class B ordinary shares outstanding for the periods. Non-redeemable Class B ordinary shares include the Founder Shares as these ordinary shares do not have any redemption features and do not participate in the income earned on the Trust Account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.
Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.
Level 3 Inputs: Significant inputs into the valuation model are unobservable.
The Company does not have any recurring Level 3 assets or liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” The Company’s derivative instruments are recorded at fair value as of the closing date of the Initial Public Offering (July 20, 2021) and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the Public Warrants and the Private Placement Warrants are a derivative instrument. As the Public Warrants and the Private Placement Warrants meet the definition of a derivative, the Public Warrants and the Private Placement Warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.
21
Table of Contents
Warrant Instruments
The Company will account for the Public Warrants and the Private Placement Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC 815, “Derivatives and Hedging” whereby under that provision the Public Warrants and the Private Placement Warrants do not meet the criteria for equity treatment and must be recorded as a liability. Accordingly, the Company classifies the warrant instrument as a liability at fair value and adjust the instrument to fair value at each reporting period. This liability will be re-measured at each balance sheet date until the Public Warrants and the Private Placement Warrants are exercised or expire, and any change in fair value will be recognized in the Company’s statement of operations. The fair value of the Public Warrants and the Private Placement Warrants will be estimated using an internal valuation model. The Company’s valuation model utilizes inputs and other assumptions and may not be reflective of the price at which they can be settled. Such warrant classification is also subject to re-evaluation at each reporting period.
Recent Accounting Pronouncements
Our management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020- 06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2021 and the adoption of such did not have on its financial position, results of operations or cash flows.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that as of September 30, 2022, our disclosure controls and procedures were not effective due to a material weakness in internal controls over financial reporting related to the lack of ability to account for complex financial instruments and a material weakness in internal controls over financial reporting related to accuracy and completeness of accounting for accounts payable and accrued expenses including contractual arrangement. The material weakness related to lack of ability to account for complex financial instruments resulted in the restatement of our previously filed balance sheet as of July 20, 2021 included in exhibit 99.1 to our Form 8-K filed on July 27, 2021 and such material weakness has not been remediated as of September 30, 2022. In addition, management identified errors in the accounting of account payable and accrued expenses in our financial statements as of December 31, 2021 and for the period from March 3, 2021 (inception) through December 31, 2021 and our financial statements as of and for the quarterly period ended March 31, 2022. We filed amendments to our Annual Report on Form 10-K filed with the SEC on February 28, 2022 and our Quarterly Report on Form 10-Q filed with the SEC on May 16, 2022 to restate the affected financial statements.
22
Table of Contents
To address the material weaknesses, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting and to provide processes and controls over the internal communications within the Company, service providers, financial advisors, and independent registered public accounting firm. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance these processes to better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our financial statements. We plan to include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. While we have processes to identify contractual agreements for accruals, we will create additional controls over tracking of accruals on services rendered or products sold to the Company. Under the oversight of the audit committee of the board of directors of the Company (the “Audit Committee”), the Company will enhance and supplement its review process with respect to quarterly and annual provision in terms of the accuracy and completeness of financial positions such as procedures to ensure that accounting periods are closed in a timely manner and controls to support the accuracy of material accruals including those accruals that are highly judgmental in nature. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. Other than the foregoing, our disclosure controls and procedures were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the foregoing information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the period from July 1, 2022 through September 30, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our Annual Report on Form 10-K/A for the year ended December 31, 2021 and our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 filed with the SEC on August 22, 2022. As of the date of this report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K/A and our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 except as follows.
We will be a passive foreign investment company, or “PFIC,” if we do not complete a business combination before 2023, which could result in adverse U.S. federal income tax consequences to U.S. investors.
If we are a PFIC for any taxable year that is included in the holding period of a U.S. investor in our Class A ordinary shares or warrants, the U.S. investor may be subject to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status for our current taxable year and subsequent taxable years may depend on whether we qualify for the PFIC start-up exception with respect to our taxable year ended December 31, 2021 (see the section of our IPO prospectus captioned “Taxation—United States Federal Income Tax Considerations—Passive Foreign Investment Company Rules”). In order to qualify for the start-up exception, we must complete a business combination before 2023 and we must not be a PFIC for our taxable years ending December 31, 2022 and December 31, 2023. In addition, even if our business combination is completed before 2023, it is possible that the start-up exception will not be available due to the structure or timing of our business combination, which are not known yet. If the completion of a business combination does not occur until after December 31, 2022, the start-up exception will not apply with respect to our taxable year ended December 31, 2021. If we do not qualify for the start-up exception, then we would be a PFIC for our taxable year ended December 31, 2021 and, based on the expected composition of our income and assets, our current taxable year. Our actual PFIC status for any taxable year will not be determinable until after the end of such taxable year (and, in the case of the start-up exception, if applicable, possibly not until after the end of the second taxable year following our 2021 taxable year). A U.S. shareholder (but not warrant holder) may be able to mitigate the adverse U.S. federal income tax consequences under the PFIC rules by making a timely “qualified electing fund,” or “QEF,” election with respect to our Class A ordinary shares to include in its income the U.S. shareholder’s pro rata share of our earnings on a current basis, whether or not they are distributed. We will endeavor to provide a PFIC Annual Information Statement (which we may post on our website) in order to enable U.S. shareholders to make and maintain a QEF election. However, there can be no assurance that we will timely provide the required information necessary to make a QEF election for any taxable year, and such election would be unavailable with respect to our warrants in all cases. U.S. investors should consult their tax advisers regarding the possible application of the PFIC rules and, in the case of U.S. shareholders, the effect of any QEF election. For a more detailed explanation, see the section of our IPO prospectus under the caption “Taxation—United States Federal Income Tax Considerations—Passive Foreign Investment Company Rules.”
23
Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities
During the quarter ended September 30, 2022, there were no unregistered sales of our equity securities. For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report on Form 10-Q.
During the quarter ended September 30, 2022, we did not repurchase any shares of our equity securities.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
24
Table of Contents
Item 6. Exhibits
* | Filed herewith. |
** | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
25
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 9, 2022
BLACK SPADE ACQUISITION CO | ||||
By: | /s/ Chi Wai Dennis Tam | |||
Name: | Chi Wai Dennis Tam | |||
Title: | Chairman and Co-Chief Executive Officer (Principal Executive Officer) | |||
By: | /s/ Francis Chi Yin Ng | |||
Name: | Francis Chi Yin Ng | |||
Title: | President and Chief Financial Officer (Principal Financial and Accounting Officer) |
26